<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ding C</submitter><funding>Jiangsu Provincial medical innovation team</funding><funding>Suzhou key medicine center</funding><funding>Suzhou Health Bureau fund</funding><funding>Project funded by China Postdoctoral Science Fundation</funding><funding>Suzhou science and technology for people&amp;apos;s livelihood</funding><funding>Suzhou introduce expert team of clinical medicine</funding><funding>Maternal and health care project of Jiangsu Province- assisted reproduction medicine center</funding><pagination>55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5845161</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>BACKGROUND:Although many reports show that various kinds of stem cells have the ability to recover function in premature ovarian aging, few studies have looked at stem cell treatment of natural ovarian aging (NOA). We designed this experimental study to investigate whether human amniotic mesenchymal stem cells (hAMSCs) retain the ability to restore ovarian function, and how hAMSCs work in this process. METHODS:To build the NOA mouse model, the mice were fed for 12-14 months normally with young fertile female mice as the normal control group (3-5 months old). Hematoxylin and eosin staining permitted follicle counting and showed the ovarian tissue structure. An enzyme-linked immunosorbent assay was used to detect the serum levels of the sex hormones estradiol (E2), anti-mullerian hormone (AM</pubmed_abstract><journal>Stem cell research &amp; therapy</journal><pubmed_title>Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor.</pubmed_title><pmcid>PMC5845161</pmcid><funding_grant_id>SYS201771</funding_grant_id><funding_grant_id>FKX201224</funding_grant_id><funding_grant_id>SZZX201505</funding_grant_id><funding_grant_id>SZYJTD201708</funding_grant_id><funding_grant_id>2017M611871</funding_grant_id><funding_grant_id>CXTDB2017013</funding_grant_id><funding_grant_id>lczx201411</funding_grant_id><pubmed_authors>Lv J</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Ding C</pubmed_authors><pubmed_authors>Ling M</pubmed_authors><pubmed_authors>Zou Q</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Chen R</pubmed_authors><pubmed_authors>Huang B</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Wu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor.</name><description>BACKGROUND:Although many reports show that various kinds of stem cells have the ability to recover function in premature ovarian aging, few studies have looked at stem cell treatment of natural ovarian aging (NOA). We designed this experimental study to investigate whether human amniotic mesenchymal stem cells (hAMSCs) retain the ability to restore ovarian function, and how hAMSCs work in this process. METHODS:To build the NOA mouse model, the mice were fed for 12-14 months normally with young fertile female mice as the normal control group (3-5 months old). Hematoxylin and eosin staining permitted follicle counting and showed the ovarian tissue structure. An enzyme-linked immunosorbent assay was used to detect the serum levels of the sex hormones estradiol (E2), anti-mullerian hormone (AM</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2025-04-04T09:05:36.138Z</modification><creation>2019-03-26T23:17:59Z</creation></dates><accession>S-EPMC5845161</accession><cross_references><pubmed>29523193</pubmed><doi>10.1186/s13287-018-0781-9</doi></cross_references></HashMap>